tiprankstipranks
Hydration Pharmaceuticals Co. Ltd. (AU:HPC)
ASX:HPC
Australian Market

Hydration Pharmaceuticals Co. Ltd. (HPC) Share Price & Analysis

1 Followers

HPC Stock Chart & Stats

Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.01 - AU$0.07
Previous CloseAU$0.01
Volume80.00K
Average Volume (3M)138.50K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$10.67M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.2
Beta0.42
Aug 28, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume138,503
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.00
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

1.26%0.00%0.00%98.74%
0.00% Other Institutional Investors
98.74% Public Companies and
Individual Investors

HPC FAQ

What was Hydration Pharmaceuticals Co. Ltd.’s price range in the past 12 months?
Hydration Pharmaceuticals Co. Ltd. lowest share price was AU$0.01 and its highest was AU$0.07 in the past 12 months.
    What is Hydration Pharmaceuticals Co. Ltd.’s market cap?
    Currently, no data Available
    When is Hydration Pharmaceuticals Co. Ltd.’s upcoming earnings report date?
    Hydration Pharmaceuticals Co. Ltd.’s upcoming earnings report date is Aug 28, 2024 which is in 105 days.
      How were Hydration Pharmaceuticals Co. Ltd.’s earnings last quarter?
      Hydration Pharmaceuticals Co. Ltd. released its earnings results on Feb 28, 2024. The company reported -AU$0.031 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.031.
        Is Hydration Pharmaceuticals Co. Ltd. overvalued?
        According to Wall Street analysts Hydration Pharmaceuticals Co. Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Hydration Pharmaceuticals Co. Ltd. pay dividends?
          Hydration Pharmaceuticals Co. Ltd. does not currently pay dividends.
          What is Hydration Pharmaceuticals Co. Ltd.’s EPS estimate?
          Hydration Pharmaceuticals Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Hydration Pharmaceuticals Co. Ltd. have?
          Hydration Pharmaceuticals Co. Ltd. has 304,913,100 shares outstanding.
            What happened to Hydration Pharmaceuticals Co. Ltd.’s price movement after its last earnings report?
            Hydration Pharmaceuticals Co. Ltd. reported an EPS of -AU$0.031 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Hydration Pharmaceuticals Co. Ltd.?
              Currently, no hedge funds are holding shares in AU:HPC
              ---

              Hydration Pharmaceuticals Co. Ltd. Stock Smart Score

              Company Description

              Hydration Pharmaceuticals Co. Ltd.

              The Hydration Pharmaceuticals Co Ltd is engaged in the marketing and sale of liquid, tablet and powder hydration solution products into the North American markets of Canada and the United States. Some of its products include Hydration + Immune System Boost, Effervescent Electrolyte Tablets, Oral Rehydration Solution, and Immunity Booster Bundle.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Holista Colltech Limited
              AdAlta Ltd.
              Hexima Ltd
              Anatara Lifesciences Ltd
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis